Drug intelligence / Profile preview

DimoVena

Development stage
Unknown
Lead developer
Kéri Pharma
Modality
Small Molecules
Administration
Topical
01

Overview

DimoVena is a cosmetic topical foam developed by Kéri Pharma, a Hungarian pharmaceutical company. It is specifically formulated to provide relief for tired and heavy legs, symptoms often associated with chronic venous insufficiency. The product features a triple-action composition of active ingredients: diosmin, menthol, and panthenol. Menthol acts as a cooling agent by stimulating TRPM8 receptors, providing an immediate refreshing sensation. Diosmin, a bioflavonoid, is included for its traditional venotonic and vasoprotective properties, which help improve microcirculation and reduce the feeling of heaviness. Panthenol (provitamin B5) serves as a skin-conditioning agent to soothe and protect the skin. DimoVena is delivered as a "crackling foam" (sercegő hab), a specialized formulation that enhances the cooling and sensory effect upon application. It is marketed as a cosmetic product rather than a pharmaceutical medicine.

Brand names
DimoVenaDimoVena sercegő hab
Other names
DimoVena crackling foam
02

Targets

TRPM8 (Transient receptor potential cation channel subfamily M member 8)

Beyond the preview

Go deeper on DimoVena.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DimoVena.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call